A Decade of Genomics Innovation at Google
Over the past decade, Google has achieved significant milestones and breakthroughs in genomics research, advancing our understanding and applications of genetic science.
DeepSomatic: Accelerating Cancer Genetic Analysis with Open-Source AI
DeepSomatic is a cutting-edge open-source AI tool that streamlines the detection of intricate genetic variants in cancer cells, significantly advancing research capabilities in oncology.
California to Launch State-Sold Affordable Insulin Pens to Challenge Pharma Industry
California is pioneering an initiative to sell low-cost insulin pens starting January, aiming to reduce dependency on pharmaceutical companies and make diabetes care more affordable.
FDA Grants First Nine Priority Review Vouchers to Accelerate Drug Approvals
The FDA has awarded the first nine priority review vouchers to expedite the evaluation of drugs targeting critical national health issues, enhancing speed to market for vital treatments.
Kaiser Permanente and DOJ Close to Settling $1 Billion Medicare Fraud Allegations
Kaiser Permanente is nearing a settlement with the DOJ over allegations of Medicare fraud involving the alteration of patient records to inflate the severity of illnesses and boost revenue. The case involves nearly $1 billion in claims and highlights concerns about healthcare fraud and oversight.
Amgen Addresses Uncertainties Surrounding Its Gastric Cancer Treatment
Amgen is working to resolve uncertainties about its gastric cancer drug by providing additional information and insights, helping to clarify its clinical prospects and development status.
Merck Unveils Promising Cancer Drugs at Major Conference, Aiming to Secure Its Future
Merck showcased important new data on cancer therapies at a major conference, highlighting drugs that are key to its strategic future in the healthcare sector.
Smart Glasses and Retinal Implants Help Restore Vision for Blind Patients
A clinical trial showed that smart glasses paired with a retinal implant helped patients with age-related macular degeneration partially regain central vision. The implant uses electrical signals to stimulate the optic nerve based on images from smart glasses, enabling improved sight for daily activities. This innovative technology was developed and advanced by Science Corporation.
UK Startup CoMind Secures Over $100M to Advance Non-Drill Brain Monitoring Technology
CoMind, a UK startup, raised over $100 million to develop non-invasive brain monitoring and treatment technology that avoids drilling into the skull. This innovation promises safer neurological care and improved patient outcomes, reflecting strong investor confidence in the technology's potential.
New Treatment Options Emerging for Aggressive Breast Cancer Following Successful AstraZeneca and Gilead Trials
AstraZeneca and Gilead have reported successful trial results for new treatments targeting aggressive breast cancer. These advancements may soon offer patients improved therapeutic options and hope for better disease management.
Concerns Rise Over Use of AI-Generated 'Poverty Porn' Images by Aid Organizations
Leading NGOs are using AI-generated images of poverty in social media campaigns, raising ethical concerns about consent and exploitation. Experts warn this trend signals a new wave of 'poverty porn,' driven by cost and accessibility factors.
Galway Scientists Achieve Major Milestone in Bowel Cancer Immunotherapy Research
Researchers in Galway have made a significant breakthrough by better understanding the immune response to bowel cancer, which could lead to new immunotherapy treatments for affected patients.
NEJM and Public Health Group Announce New Rival to CDC's MMWR Publication
The New England Journal of Medicine (NEJM) and a public health organization are collaborating to launch a new publication that will compete with the CDC's Morbidity and Mortality Weekly Report, aiming to offer an alternative resource for public health information and reporting.
New Research at ESMO 2025 Boosts Potential of Blood Tests in Cancer Treatment Guidance
Data from ESMO 2025 highlights promising advances in blood tests that could help tailor cancer treatment by identifying patients who need extra therapy and those who do not, potentially improving personalized care.
Abridge and OpenEvidence Enter Competitive Phase in AI for Healthcare
Abridge and OpenEvidence, two artificial intelligence startups in healthcare, are shifting from distinct operations to direct competition for physician users, as highlighted in their recent announcements at HLTH.
AMA Launches Center for Digital Health and AI Amidst Debates on AI Regulation
The American Medical Association has established a Center for Digital Health and AI to address challenges and opportunities in health technology. AMA CEO John Whyte shares details about the center's objectives and its role in the ongoing debate over AI regulation in healthcare.
Doctor Mike Advocates for Improved Social Media Strategies in Medicine
Doctor Mike, a well-known YouTuber, suggests that the medical field should adopt better social media strategies to counteract declining trust in public health institutions and improve public engagement.
Reflecting on Covid Origins and Public Health's Challenge with Uncertainty
The Covid pandemic highlighted significant challenges in public health, particularly its handling of uncertainty. Improving this aspect is essential for more effective future responses.
Colorado Clinic Embraces Medicaid with Easy Access and No Insurance Hassles
A Colorado clinic uniquely supports Medicaid patients by providing healthcare access without the need for appointments, nurses, or private insurance, contrasting with many facilities that avoid Medicaid.
Irish AI Start-Up Meta-Flux Secures €1.8M to Enhance Drug Precision
Meta-Flux, an Irish AI start-up, has raised €1.8 million to improve drug accuracy. The company is expanding its technical team in Ireland and reinforcing its foothold in both the US and Europe to advance its innovative healthcare solutions.